Suven Pharmaceuticals Q3 Results

  • BSE: 543064
  • NSE: SUVENPHAR
  • ISIN: INE03QK01018
  • Sector: Biotechnology & Drugs
BSE
642.59.35 (1.48%)
Volume4.42 K
Updated: Tue 28 May, 2024 | 15:28:03
NSE
643.18.50 (1.34%)
Volume77.28 K
Updated: Tue 28 May, 2024 | 15:44:08
Today: 630.55
644.50
52-Wk: 427.05
767.00

Q3 Results Highlights

  • Total Income
    ₹219.82 Cr.
    (-37.86%)
  • Operating Profit
    ₹52.39 Cr.
    (-61.03%)
  • Profit After Tax
    ₹46.75 Cr.
    (-56.60%)
  • Operating Margin
    23.83%
    (-37.29%)
Note: Comparison is on YoY basis

Quarterly - Suven Pharmaceuticals Q3 Results

*All figures in crores except per share values
Fiscal PeriodDec 23Sep 23QoQ CompDec 22YoY Comp
Total Revenue 219.82231.05-4.86%353.77-37.86%
Selling/ General/ Admin Expenses Total 32.8328.5814.89%29.6810.64%
Depreciation/ Amortization 12.7511.897.23%12.244.19%
Other Operating Expenses Total 14.4213.169.56%18.13-20.47%
Total Operating Expense 167.43144.9815.48%219.32-23.66%
Operating Income 52.3986.07-39.13%134.46-61.03%
Net Income Before Taxes 65.47105.41-37.89%146.08-55.18%
Net Income 46.7579.56-41.24%107.72-56.60%
Diluted Normalized EPS 1.843.13-41.21%4.23-56.50%

Recommended For You

    More Recommendations

    Trending Stocks

      Subscribe to Our Newsletter

      Get daily newsletters around different themes from livemint.

      Subscribe
      HomeMarketsPremiumFor youGet App